Genetic suppression of the APP level resulted in a normalization of EEG activity (Born et al., 2014) as well as the tau reduction was beneficial for animals in multiple models of AD (Roberson et al., 2007, 2011; Gómez de Barreda et al., 2010; Ittner et al., 2010). This evidence concerns the gene MAPT and Alzheimer disease.